AIDS INDs: FDA
Executive Summary
AIDS INDs: FDA Commissioner Young announced at a Jan. 29 press briefing that there are currently 112 active INDs for AIDS therapies. Young said that FDA has received 128 IND applications covering 75 products: 17 antiviral drugs; 4 vaccines; 15 drugs for opportunistic infections; 37 immunomodulators and 4 antineoplastics.